Literature DB >> 19258277

Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.

Santosh K Katiyar1, Thomas D Edlind.   

Abstract

The opportunistic mold Fusarium solani is intrinsically resistant to cell wall synthesis-inhibiting echinocandins (ECs), including caspofungin and micafungin. Mutations that confer acquired EC resistance in Saccharomyces cerevisiae and other normally susceptible yeast species have been mapped to the Fks1 gene; among these is the mutation of residue 639 from Phe to Tyr (F639Y) within a region designated hot spot 1. Fks1 sequence analysis identified the equivalent of Y639 in F. solani as well as in Scedosporium prolificans, another intrinsically EC-resistant mold. To test its role in intrinsic EC resistance, we constructed Fks1 hybrids in S. cerevisiae that incorporate F. solani hot spot 1 and flanking residues. Hybrid construction was accomplished by a PCR-based method that was validated by studies with Fks1 sequences from EC-susceptible Aspergillus fumigatus and paired EC-susceptible and -resistant Candida glabrata isolates. In support of our hypothesis, hybrid Fks1 incorporating F. solani hot spot 1 conferred significantly reduced EC susceptibility, 4- to 8-fold less than that of wild-type S. cerevisiae and 8- to 32-fold less than that of the same hybrid with an F639 mutation. We propose that Fks1 sequences represent determinants of intrinsic EC resistance in Fusarium and Scedosporium species and, potentially, other fungi.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258277      PMCID: PMC2681557          DOI: 10.1128/AAC.00020-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.

Authors:  Eleusa Maria F Rocha; Guillermo Garcia-Effron; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

Review 2.  Resistance to echinocandin-class antifungal drugs.

Authors:  David S Perlin
Journal:  Drug Resist Updat       Date:  2007-06-13       Impact factor: 18.500

3.  Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.

Authors:  Santosh Katiyar; Michael Pfaller; Thomas Edlind
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Manganese superoxide dismutase based phylogeny of pathogenic fungi.

Authors:  Emilie Fréalle; Christophe Noël; Nicole Nolard; Françoise Symoens; Maria-Sueli Felipe; Eduardo Dei-Cas; Daniel Camus; Eric Viscogliosi; Laurence Delhaes
Journal:  Mol Phylogenet Evol       Date:  2006-05-12       Impact factor: 4.286

5.  In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

Review 6.  Changing epidemiology of rare mould infections: implications for therapy.

Authors:  Anurag N Malani; Carol A Kauffman
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Update on echinocandin antifungals.

Authors:  Carol A Kauffman; Peggy L Carver
Journal:  Semin Respir Crit Care Med       Date:  2008-04       Impact factor: 3.119

Review 8.  Changing epidemiology of systemic fungal infections.

Authors:  M Richardson; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2008-05       Impact factor: 8.067

9.  Rho1 has distinct functions in morphogenesis, cell wall biosynthesis and virulence of Fusarium oxysporum.

Authors:  Ana Lilia Martínez-Rocha; M Isabel G Roncero; Adriana López-Ramirez; Marçal Mariné; Josep Guarro; Guadalupe Martínez-Cadena; Antonio Di Pietro
Journal:  Cell Microbiol       Date:  2008-02-01       Impact factor: 3.715

10.  Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.

Authors:  Graeme N Forrest; Elizabeth Weekes; Jennifer K Johnson
Journal:  J Infect       Date:  2007-12-21       Impact factor: 6.072

View more
  26 in total

1.  Topological and mutational analysis of Saccharomyces cerevisiae Fks1.

Authors:  Michael E Johnson; Thomas D Edlind
Journal:  Eukaryot Cell       Date:  2012-05-11

2.  Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin.

Authors:  A Fekkar; I Meyer; J Y Brossas; E Dannaoui; M Palous; M Uzunov; S Nguyen; V Leblond; D Mazier; A Datry
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

Review 3.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

Review 4.  Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.

Authors:  David S Perlin
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

5.  New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species.

Authors:  Michael E Johnson; Santosh K Katiyar; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

6.  Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.

Authors:  Wendy W J van de Sande; Ahmed H Fahal; Irma A J M Bakker-Woudenberg; Alex van Belkum
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

7.  Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.

Authors:  Santosh K Katiyar; Ana Alastruey-Izquierdo; Kelley R Healey; Michael E Johnson; David S Perlin; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

8.  Modulation of Alternaria infectoria cell wall chitin and glucan synthesis by cell wall synthase inhibitors.

Authors:  Chantal Fernandes; Jorge Anjos; Louise A Walker; Branca M A Silva; Luísa Cortes; Marta Mota; Carol A Munro; Neil A R Gow; Teresa Gonçalves
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

9.  Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.

Authors:  Catiana Dudiuk; Daiana Macedo; Florencia Leonardelli; Laura Theill; Matias S Cabeza; Soledad Gamarra; Guillermo Garcia-Effron
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

10.  Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin.

Authors:  Shaun K Morris; Upton D Allen; Sumit Gupta; Susan E Richardson
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.